IBRANCE
IBRANCE
Approved
DIN Number
02493543
Drug Class
Human
Market Date
Sep 21, 2020
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02493543
AIG Number0157970002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EF01 PALBOCICLIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PALBOCICLIBActive
Strength: 100 MG
Monograph: PALBOCICLIB